Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...
Discover how value chain analysis improves efficiency and profit margins while exploring its significant drawbacks for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results